Author:
Chen Tianlai,Shu Xiwen,Zhou Huiyuan,Beckford Floyd A.,Misir Mustafa
Abstract
AbstractThe present study investigates the use of algorithm selection for automatically choosing an algorithm for any given protein–ligand docking task. In drug discovery and design process, conceptualizing protein–ligand binding is a major problem. Targeting this problem through computational methods is beneficial in order to substantially reduce the resource and time requirements for the overall drug development process. One way of addressing protein–ligand docking is to model it as a search and optimization problem. There have been a variety of algorithmic solutions in this respect. However, there is no ultimate algorithm that can efficiently tackle this problem, both in terms of protein–ligand docking quality and speed. This argument motivates devising new algorithms, tailored to the particular protein–ligand docking scenarios. To this end, this paper reports a machine learning-based approach for improved and robust docking performance. The proposed set-up is fully automated, operating without any expert opinion or involvement both on the problem and algorithm aspects. As a case study, an empirical analysis was performed on a well-known protein, Human Angiotensin-Converting Enzyme (ACE), with 1428 ligands. For general applicability, AutoDock 4.2 was used as the docking platform. The candidate algorithms are also taken from AutoDock 4.2. Twenty-eight distinctly configured Lamarckian-Genetic Algorithm (LGA) are chosen to build an algorithm set. ALORS which is a recommender system-based algorithm selection system was preferred for automating the selection from those LGA variants on a per-instance basis. For realizing this selection automation, molecular descriptors and substructure fingerprints were employed as the features characterizing each target protein–ligand docking instance. The computational results revealed that algorithm selection outperforms all those candidate algorithms. Further assessment is reported on the algorithms space, discussing the contributions of LGA’s parameters. As it pertains to protein–ligand docking, the contributions of the aforementioned features are examined, which shed light on the critical features affecting the docking performance.
Publisher
Springer Science and Business Media LLC
Reference76 articles.
1. Everhardus, J. A. Drug Design: Medicinal Chemistry (Elsevier, 2017).
2. Jeffrey, C., Carl, R. & Parvesh, K. The price of progress: Funding and financing alzheimer’s disease drug development. Alzheimer Dementia Trans. Res. Clin. Inter. 20, 875 (2018).
3. Reymond, J.-L. The chemical space project. Acc. Chem. Res. 48(3), 722–730 (2015).
4. Mullard, A. 2020 fda drug approvals. Nat. Rev. Drug Discov. 20(2), 85–91 (2021).
5. Edgar, L.-L., Jurgen, B. & Jose, L.M.-F. Informatics for chemistry, biology, and biomedical sciences. J. Chem. Inf. Model. 61(1), 26–35 (2020).
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献